BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26097986)

  • 1. A Bolus and Bolus Followed by Infusion Study of AZD3043, an Investigational Intravenous Drug for Sedation and Anesthesia: Safety and Pharmacodynamics in Healthy Male and Female Volunteers.
    Norberg Å; Koch P; Kanes SJ; Björnsson MA; Barassin S; Ahlén K; Kalman S
    Anesth Analg; 2015 Oct; 121(4):894-903. PubMed ID: 26097986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First Human Study of the Investigational Sedative and Anesthetic Drug AZD3043: A Dose-Escalation Trial to Assess the Safety, Pharmacokinetics, and Efficacy of a 30-Minute Infusion in Healthy Male Volunteers.
    Kalman S; Koch P; Ahlén K; Kanes SJ; Barassin S; Björnsson MA; Norberg Å
    Anesth Analg; 2015 Oct; 121(4):885-893. PubMed ID: 26111262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Recirculatory Model for Pharmacokinetics and the Effects on Bispectral Index After Intravenous Infusion of the Sedative and Anesthetic AZD3043 in Healthy Volunteers.
    Björnsson MA; Norberg Å; Kalman S; Simonsson USH
    Anesth Analg; 2015 Oct; 121(4):904-913. PubMed ID: 26097984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics.
    Antonik LJ; Goldwater DR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):274-83. PubMed ID: 22190555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Phase 1, Single-center, Double-blind, Placebo-controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Clinical Effects, and Pharmacokinetics-Pharmacodynamics of Intravenous Cyclopropyl-methoxycarbonylmetomidate (ABP-700) after a Single Ascending Bolus Dose.
    Struys MMRF; Valk BI; Eleveld DJ; Absalom AR; Meyer P; Meier S; den Daas I; Chou T; van Amsterdam K; Campagna JA; Sweeney SP
    Anesthesiology; 2017 Jul; 127(1):20-35. PubMed ID: 28459733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HTX-019 via 2-min injection or 30-min infusion in healthy subjects.
    Ottoboni T; Lauw M; Keller MR; Cravets M; Manhard K; Clendeninn N; Quart B
    Future Oncol; 2019 Mar; 15(8):865-874. PubMed ID: 30574797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
    Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, open-label study of the safety and tolerability of fospropofol for patients requiring intubation and mechanical ventilation in the intensive care unit.
    Candiotti KA; Gan TJ; Young C; Bekker A; Sum-Ping ST; Kahn R; Lebowitz P; Littman JJ
    Anesth Analg; 2011 Sep; 113(3):550-6. PubMed ID: 21596879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sedation Effects Produced by a Ciprofol Initial Infusion or Bolus Dose Followed by Continuous Maintenance Infusion in Healthy Subjects: A Phase 1 Trial.
    Hu C; Ou X; Teng Y; Shu S; Wang Y; Zhu X; Kang Y; Miao J
    Adv Ther; 2021 Nov; 38(11):5484-5500. PubMed ID: 34559359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clevidipine: a review of its use in the management of acute hypertension.
    Deeks ED; Keating GM; Keam SJ
    Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A population pharmacokinetic/pharmacodynamic analysis of regadenoson, an adenosine A2A-receptor agonist, in healthy male volunteers.
    Gordi T; Frohna P; Sun HL; Wolff A; Belardinelli L; Lieu H
    Clin Pharmacokinet; 2006; 45(12):1201-12. PubMed ID: 17112296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralization of alpha(2)-antiplasmin by microplasmin: a randomized, double-blind, placebo-controlled, ascending-dose study in healthy male volunteers.
    Pakola S; Cahillane G; Stassen JM; Lijnen HR; Verhamme P
    Clin Ther; 2009 Aug; 31(8):1688-706. PubMed ID: 19808128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of alfentanil and propofol for outpatient monitored anesthesia care: determining the optimal dosing regimen.
    Avramov MN; White PF
    Anesth Analg; 1997 Sep; 85(3):566-72. PubMed ID: 9296410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, placebo-controlled, multicenter, repeat-dose study of two intravenous acetaminophen dosing regimens for the treatment of pain after abdominal laparoscopic surgery.
    Wininger SJ; Miller H; Minkowitz HS; Royal MA; Ang RY; Breitmeyer JB; Singla NK
    Clin Ther; 2010 Dec; 32(14):2348-69. PubMed ID: 21353105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety, pharmacokinetic and pharmacodynamic properties of single ascending dose and continuous infusion of remimazolam besylate in healthy Chinese volunteers.
    Sheng XY; Liang Y; Yang XY; Li LE; Ye X; Zhao X; Cui YM
    Eur J Clin Pharmacol; 2020 Mar; 76(3):383-391. PubMed ID: 31873765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics, safety and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in volunteers with mild iron-deficiency anaemia.
    Geisser P; Banké-Bochita J
    Arzneimittelforschung; 2010; 60(6a):362-72. PubMed ID: 20648928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexmedetomidine as a Rapid Bolus for Treatment and Prophylactic Prevention of Emergence Agitation in Anesthetized Children.
    Hauber JA; Davis PJ; Bendel LP; Martyn SV; McCarthy DL; Evans MC; Cladis FP; Cunningham S; Lang RS; Campbell NF; Tuchman JB; Young MC
    Anesth Analg; 2015 Nov; 121(5):1308-15. PubMed ID: 26332857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained exposure to the investigational Kisspeptin analog, TAK-448, down-regulates testosterone into the castration range in healthy males and in patients with prostate cancer: results from two phase 1 studies.
    MacLean DB; Matsui H; Suri A; Neuwirth R; Colombel M
    J Clin Endocrinol Metab; 2014 Aug; 99(8):E1445-53. PubMed ID: 24762108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I, dose-escalation trial evaluating the safety and efficacy of emulsified isoflurane in healthy human volunteers.
    Huang H; Li R; Liu J; Zhang W; Liao T; Yi X
    Anesthesiology; 2014 Mar; 120(3):614-25. PubMed ID: 24162462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychomotor Recovery Following Remimazolam-induced Sedation and the Effectiveness of Flumazenil as an Antidote.
    Chen X; Sang N; Song K; Zhong W; Wang H; Jiang J; Huang Y; Hu P
    Clin Ther; 2020 Apr; 42(4):614-624. PubMed ID: 32178858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.